Growth-hormone secretagogue research is a high-volume peptide search cluster.
Also known as: CJC1295 · DAC:GRF
Part of the Growth hormone & IGF peptides cluster
Overview
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) studied for effects on the GH/IGF-1 axis. Variants with and without DAC (Drug Affinity Complex) appear in research discussions.
Source & context
Biological / chemical source: Synthetic GHRH analog
Primary research or clinical context: Research compound (not an approved drug)
With vs. without DAC
DAC-containing versions were designed to extend circulating half-life via albumin binding. Research discussions often distinguish CJC-1295 with DAC from modified GRF 1-29 (sometimes called CJC-1295 without DAC).
Stacking context (educational)
Online research communities frequently discuss CJC-1295 alongside GHRP-family peptides such as ipamorelin. This site covers mechanisms and nomenclature only — not protocols or human use guidance.
FAQ about CJC-1295
What is CJC-1295?+
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) studied for effects on the GH/IGF-1 axis. Variants with and without DAC (Drug Affinity Complex) appear in research discussions.
Is CJC-1295 an approved medicine?+
CJC-1295 is discussed here as a research / educational topic. Research compound (not an approved drug). This is not medical advice.
What is the typical length of CJC-1295?+
CJC-1295 is commonly described as approximately 30 amino acids (Research peptide).